<DOC>
	<DOCNO>NCT02281812</DOCNO>
	<brief_summary>Background/Main objective : Radiofrequency ablation ( RFA ) minimally invasive procedure widespread accept treatment different tumor , especially liver benefit yet well-known breast cancer . Our main objective evaluate usefulness RFA &lt; 2cm malignant breast tumor reduce proportion positive margin . Methodology : The investigator propose single-center , single-blind , phase I II randomize control trial . Phase I : Security cool-tip cluster electrode assess potential adverse effect three stage : initial , intermediate final . Phase II : Randomized clinical trial , 2 parallel group 37 patient one . Experimental group : percutaneous RFA previous conventional lumpectomy . Control group : conventional surgery lumpectomy . The number positive margin group , need extend margin resection assess intraoperatively . Inclusion criterion : woman &gt; 40 year , infiltrate ductal breast carcinoma biopsy . The tumor must unique , visible ultrasound , small 2cm locate &gt; 1 cm chest wall skin . Patients follow period two year assess cosmetic result , short -term long -term complication recurrence . Expected result : The `` cool-tip '' ( cluster ) ablation method reduces least 30 % risk intraoperative extension positive margin lumpectomy compare conventional surgery breast tumor diameter &lt; 2 cm . Therefore procedure may reduce risk second surgery remove volume tissue.Consequently final cosmetic result improve .</brief_summary>
	<brief_title>Radiofrequency Ablation Breast Cancer</brief_title>
	<detailed_description>Main objective project : - To evaluate usefulness radiofrequency ablation ( RFA ) achieve low percentage positive margin . - To validate clinically efficacy safety method breast tumor small &lt; 2 cm . Specific objective project : 1 . To demonstrate , RFA , clear margin increase intraoperative pathological analysis compare conventional surgery . 1 . To quantify number positive margin require intraoperative extension patient , compare ratio group . 2 . To quantify percentage patient require intraoperative extension compare group . 2 . To demonstrate reduction volume breast tissue remove RFA compare conventional surgery . 1 . Comparing group anteroposterior , transverse craniocaudal diameter excise specimen , measure cm , calculate volume . 2 . Tumor weight gram ( include extension ) measure compare weight group . 3 . To evaluate difference cosmetic outcome RFA versus conventional surgery . . An international scale use score compare . There two independent assessment , one physician another patient . 4 . To demonstrate effectiveness RFA cluster `` cool-tip '' electrode experimental group . 1 . RFA consider complete viable tumor tissue evidence oxidation-reduction reaction mediate NADH-diaphorase surgical resection . Mitochondrial dysfunction also evaluate semiquantitative quantitative method use enzyme cytochrome c oxidase Complex IV ( COX ) tunel . Any residual viable tumor tissue consider incomplete RFA . 2 . Risk factor incomplete ablation analyze , especially tumor vascularization . 5 . To demonstrate safety RFA cluster `` cool-tip '' electrode breast cancer tumor . To quantify side effect may occur RFA / surgery correlate complication rate group severity .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Breast single tumor , Clearly visible ultrasound , Diameter &lt; 2 cm Located &gt; 1 cm chest wall skin ; Ductal carcinoma accord previous biopsy , &lt; 20 % intraductal carcinoma Breast cancer men ; Personal history ipsilateral breast cancer ; Age &lt; 40 year ; Pregnancy breastfeeding ; Suspicion intraductal extension multifocality mammography MRI ; Tumour visible ultrasound ; Diameter &gt; 2 cm ; Distance muscle skin &lt; 1 cm ; Lobular carcinoma ; Intraductal carcinoma &gt; 20 % biopsy sample Patients undergo neoadjuvant chemotherapy hormonotherapy .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Ablation Technique</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Stage 1</keyword>
	<keyword>Lumpectomy</keyword>
</DOC>